Luminopia is pioneering a new class of treatments for significant neuro-visual disorders. Luminopia is committed to creating digital therapeutics that are both rigorously evaluated for FDA approval and genuinely engaging for patients. The company is developing its lead product, Luminopia One, to improve vision in children with amblyopia, the leading cause of vision less among children.

​